Judy Chou, Ph.D. State Treasurer Fiona Ma appointed Judy Chou, Ph.D., to the CIRM Board. Dr. Chou will serve as the Executive Officer of a Commercial Life Science entity, replacing Dave Martin. Dr. Chou is President and CEO of AltruBio, a clinical‑stage biotech company. AltruBio develops antibody therapeutics for immune inflammatory diseases. She also serves … Continue reading Judy Chou newest member of CIRM Board
Genentech
Stem Cell RoundUp: CIRM Clinical Trial Updates & Mapping Human Brain
It was a very CIRMy news week on both the clinical trial and discovery research fronts. Here are some the highlights: Stanford cancer-fighting spinout to Genentech: 'Don't eat me' – San Francisco Business Times Ron Leuty, of the San Francisco Business Times, reported this week on not one, but two news releases from CIRM grantee … Continue reading Stem Cell RoundUp: CIRM Clinical Trial Updates & Mapping Human Brain
Engaging the patient to create a culture of health citizenship
One of the buzz phrases in healthcare today is “patient engagement”. It seems that you can’t go to a medical or scientific conference without coming across a panel discussion on the topic. A recent Partnering For Cures* event in San Francisco was no exception. But here the conversation took on a very different tone, one … Continue reading Engaging the patient to create a culture of health citizenship